Details for New Drug Application (NDA): 019983
✉ Email this page to a colleague
The generic ingredient in PROSTEP is nicotine. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nicotine profile page.
Summary for 019983
Tradename: | PROSTEP |
Applicant: | Aveva |
Ingredient: | nicotine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019983
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 11MG/24HR | ||||
Approval Date: | Dec 23, 1998 | TE: | RLD: | No |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 22MG/24HR | ||||
Approval Date: | Dec 23, 1998 | TE: | RLD: | No |
Expired US Patents for NDA 019983
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aveva | PROSTEP | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 019983-003 | Dec 23, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Aveva | PROSTEP | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 019983-004 | Dec 23, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription